DAWN: Day One Biopharmaceuticals, Inc. Stock

by  •  • Comments Off on DAWN: Day One Biopharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 726.71
Enterprise Value ($M) 693.35
Book Value ($M) 479.51
Book Value / Share 4.73
Price / Book 1.52
NCAV ($M) 453.81
NCAV / Share 4.48
Price / NCAV 1.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.14
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.23

Liquidity (mrq)
Quick Ratio 10.55
Current Ratio 10.62

Balance Sheet (mrq) ($M)
Current Assets 508.65
Assets 534.36
Liabilities 54.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 131.16
Operating Income -212.27
Net Income -95.50

Cash Flow Statement (mra) ($M)
Cash From Operations -78.11
Cash from Investing -230.99
Cash from Financing 203.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-28 13G/A BlackRock, Inc. 4.70 -6.12
02-14 13G/A Ra Capital Management, L.p. 5.70 -26.30
02-12 13G/A Fmr Llc 12.80 14.18
11-14 13G/A Atlas Venture Fund XI, L.P. 5.50 -19.48
08-05 13D/A AI Day1 LLC 13.15 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 183,163 1,209,805 15.14
2025-06-05 125,630 612,124 20.52
2025-06-04 145,839 713,409 20.44
2025-06-03 303,757 1,442,165 21.06
2025-06-02 404,961 1,984,931 20.40

(click for more detail)

Similar Companies
CRNX – Crinetics Pharmaceuticals, Inc. CTMX – CytomX Therapeutics, Inc.
CYTK – Cytokinetics, Incorporated DNLI – Denali Therapeutics Inc.
DSGN – Design Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io